YES LABS LIMITED

Financial Health Score: B-

Explanation: The patient is exhibiting a mixed physiological state. While the immediate pulse (cash position) has strengthened considerably over the year, the business is suffering from a silent fever—an operating loss that has eroded its vital reserves (retained earnings). Additionally, short-term obligations (current liabilities) are rising faster than short-term assets, putting increasing pressure on the company's circulatory system. The recent change in ultimate holding company acts as a major systemic shift, the long-term effects of which are yet to be seen.

1. Key Vital Signs

• Pulse (Cash Position): Strengthening. Cash at bank improved dramatically from £28,456 in 2023 to £93,085 in 2024. The patient's immediate liquidity pulse is much stronger than the prior year, meaning the risk of sudden cardiac arrest (insolvency) is reduced.
• Blood Pressure (Liquidity Ratio): Elevated and Strained. Current assets (£1.605m) cover current liabilities (£1.076m) at a ratio of roughly 1.49:1. While still technically healthy, this is a noticeable drop from the 2023 ratio of 1.77:1. The financial blood pressure is rising as short-term debts swell.
• Cholesterol (Debt Burden): Worsening Short-Term Blockages. Total liabilities jumped from £864,876 to £1,076,795. The most concerning spike is in "other creditors," which ballooned from £266,941 to £444,465—a £177k increase representing a significant build-up of short-term financial plaque.
• Weight Loss (Net Assets & Reserves): Unhealthy Shrinkage. Shareholders' funds dropped by £95,475 (from £593,142 to £497,667). This is entirely reflected in the P&L reserve dropping from £393,042 to £297,567, confirming the business suffered a £95,475 loss during 2024. The patient is losing body mass.

2. Symptoms Analysis

• Arteriosclerosis (Working Capital Blockages): While total current assets look robust at £1.6m, the capital is heavily trapped in slow-moving vessels. Trade debtors sit at £526,879, and a staggering £571,078 is tied up in Stocks (inventory). For a company with only £1.6m in total current assets, having over £1m locked in stock and unpaid invoices means the business's circulatory system is struggling to convert sales into fluid cash.
• Fever (Operational Loss): The drop in the P&L reserve indicates a feverish year where expenses outpaced revenues. With average employee headcount rising from 29 to 33, overheads have increased, but the top-line turnover (not explicitly stated but implied by the loss) was insufficient to cover these new costs.
• Medication Dependency (CBILS Loan): The company is actively paying down a Coronavirus Business Interruption Loan (CBILS), reducing the long-term portion from £104,167 to £54,167. While reducing long-term debt is generally healthy, the £50,000 portion moved into current liabilities, adding to the immediate blood pressure spike.
• Group Circulation (Intercompany Balances): The company has £287,481 owed by group undertakings and £83,929 owed to group undertakings. This suggests heavy reliance on the wider corporate body for cash flow and operational support, acting as a circulatory system that relies on the health of the parent.

3. Diagnosis

The patient is suffering from Acute Working Capital Strain secondary to an Operational Loss.

Although the business has successfully injected cash into its system (boosting cash reserves by over £64k), this has come at the cost of drawing down reserves and accumulating short-term creditors. The £95k loss for the year has reduced the company's financial immunity (equity buffer). The massive inventory build-up suggests products are sitting on the shelf rather than flowing through the market, which is a dangerous symptom for a manufacturing business (SIC 32500).

Furthermore, the sudden spike in "other creditors" by £177k requires investigation; this could be deferred revenue, accrued expenses, or unpaid taxes, but it acts as a growing clot in the company's short-term financial vessels. On a positive note, the ongoing repayment of the CBILS loan shows discipline in managing long-term debt, and the overall net asset position remains positive at nearly £500k, meaning the patient is not currently in critical condition.

4. Recommendations

1. Clear the Arteries (Improve Debtors & Inventory Turn): The most critical intervention is to convert stock and debtors into cash. Implement stricter credit control to chase the £526k in trade debtors, and consider discounting slow-moving inventory to reduce the £571k stock pile. The business needs fluid cash, not stagnant assets.
2. Investigate the "Other Creditors" Spike: A £177k increase in unspecified short-term creditors is a significant anomaly. Management must ensure these obligations can be met from future cash flows without starving the business of operating capital.
3. Treat the Fever (Address the Operating Loss): The addition of 4 new employees suggests expansion, but the £95k loss indicates scaling costs are outpacing revenue. The company must perform a margin analysis to ensure its pricing covers the increased overhead, or risk further erosion of shareholder funds.
4. Monitor the New Parent (Post-Acquisition Health Check): Note that post-balance sheet, the ultimate parent became Project Nazare Limited. The company should leverage this new parentage for potential strategic support, but must also guard against being drained by new group-level financial demands.